A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myeloma

Meaghan L. Khan, Craig B. Reeder, Shaji K. Kumar, Marthy Q. Lacy, Donna E. Reece, Angela Dispenzieri, Morie A. Gertz, Phillip Greipp, Suzanne Hayman, Steven Zeldenhurst, David Dingli, John Lust, Stephen Russell, Kristina M. Laumann, Joseph R. Mikhael, P. Leif Bergsagel, Rafael Fonseca, S. Vincent Rajkumar, A. Keith Stewart

Research output: Contribution to journal › Article › peer-review

47 Scopus citations

Fingerprint

Dive into the research topics of 'A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences